Entresto (Sacubitril/Valsartan)

Description

Effective Treatment for Heart Failure

Entresto (Sacubitril/Valsartan) is a combination medication used to treat heart failure. This medication combines Sacubitril, a neprilysin inhibitor, and Valsartan, an angiotensin II receptor blocker (ARB), to help relax blood vessels, reduce fluid buildup, and improve heart function.

Entresto comes in different dosages to meet individual patient needs, including:

• 24.3 mg/25.7 mg

• 48.6 mg/51.4 mg

• 97.2 mg/102.8 mg

It is proven to reduce the risk of hospitalization due to heart failure and improve survival rates for patients with heart failure with reduced ejection fraction (HFrEF).

Why Choose Entresto?

• Proven Efficacy: Reduces hospitalization and improves survival rates in heart failure patients.

• Combination Therapy: Works by blocking harmful proteins and relaxing blood vessels.

• Multiple Dosage Options: Available in 24.3 mg/25.7 mg, 48.6 mg/51.4 mg, and 97.2 mg/102.8 mg tablets for personalized treatment.

Common Usage & Dosage

Entresto is typically taken twice daily. The exact dosage is based on the patient’s specific condition and prescribed by a healthcare provider.